Contribution of autoallergy to the pathogenesis in the NOD mice

References

• Valenta, R., I. Mittermann, T. Werfel, et al. 2009. Linking allergy to autoimmune disease. Trends Immunol. 30: 109–116
   PubMed Web of Science ®Google Scholar
• Atta, A. M., M. B. Santiago, F. G. Guerra, et al. 2010. Autoimmune response of IgE antibodies to cellular self-antigens in systemic Lupus Erythematosus. Int. Arch. Allergy Immunol. 152: 401–406
   PubMed Web of Science ®Google Scholar
• Dema, B., C. Pellefigues, S. Hasni, et al. 2014. Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis. PLoS One. 9: e90424
   PubMed Web of Science ®Google Scholar
• Zuraw, B. L., C. H. O'Hair, J. H. Vaughan, et al. 1981. Immunoglobulin E-rheumatoid factor in the serum of patients with rheumatoid arthritis, asthma, and other diseases. J. Clin. Invest. 68: 1610–1613
   PubMed Web of Science ®Google Scholar
• Guo, J., B. Rapoport, and S. M. McLachlan. 1997. Thyroid peroxidase autoantibodies of IgE class in thyroid autoimmunity. Clin. Immunol. Immunopathol. 82: 157–162
   PubMedGoogle Scholar
• Messingham, K. A., H. M. Holahan, and J. A. Fairley. 2014. Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid. Immunol. Res. 59: 273–278
   PubMed Web of Science ®Google Scholar
• Petersen, J. S., P. Kulmala, J. T. Clausen, et al. 1999. Progression to type 1 diabetes is associated with a change in the immunoglobulin isotype profile of autoantibodies to glutamic acid decarboxylase (GAD65). Childhood Diabetes in Finland Study Group. Clin. Immunol. 90: 276–281
   PubMed Web of Science ®Google Scholar
• Silveira, P. A., and S. T. Grey. 2006. B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes. Trends Endocrinol. Metab. 17: 128–135
   PubMed Web of Science ®Google Scholar
• Falcone, M., J. Lee, G. Patstone, et al. 1998. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J. Immunol. 161: 1163–1168
   PubMed Web of Science ®Google Scholar
• Noorchashm, H., Y. K. Lieu, N. Noorchashm, et al. 1999. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J. Immunol. 163: 743–750
   PubMed Web of Science ®Google Scholar
• Serreze, D. V., and P. A. Silveira. 2003. The role of B lymphocytes as key antigen-presenting cells in the development of T cell-mediated autoimmune type 1 diabetes. Curr. Direct. Autoimmun. 6: 212–227
   PubMedGoogle Scholar
• Pescovitz, M. D., C. J. Greenbaum, B. Bundy, et al. 2014. B-lymphocyte depletion with rituximab and beta-cell function: two-year results. Diabetes Care. 37: 453–459
   PubMed Web of Science ®Google Scholar
• Pescovitz, M. D., C. J. Greenbaum, H. Krause-Steinrauf, et al. 2009. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N. Engl. J. Med. 361: 2143–2152
   PubMed Web of Science ®Google Scholar
• Luu, V. P., M. I. Vazquez, and A. Zlotnik. 2014. B cells participate in tolerance and autoimmunity through cytokine production. Autoimmunity. 47: 1–12
   PubMed Web of Science ®Google Scholar
• Herold, K. C., D. A. Vignali, A. Cooke, and J. A. Bluestone. 2013. Type 1 diabetes: translating mechanistic observations into effective clinical outcomes. Nat. Rev. Immunol. 13: 243–256
   PubMed Web of Science ®Google Scholar
• Taplin, C. E., and J. M. Barker. 2008. Autoantibodies in type 1 diabetes. Autoimmunity. 41: 11–18
   PubMed Web of Science ®Google Scholar
• Hampe, C. S. 2012. Protective role of anti-idiotypic antibodies in autoimmunity–lessons for type 1 diabetes. Autoimmunity. 45: 320–331
   PubMed Web of Science ®Google Scholar
• Makino, S., K. Kunimoto, Y. Muraoka, et al. 1980. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu. Exp. Anim. 29: 1–13
   PubMedGoogle Scholar
• Leijon, K., A. Freitas, and D. Holmberg. 1993. Analysis of VH gene utilisation in the non-obese diabetic mouse. Autoimmunity. 15: 11–18
   PubMed Web of Science ®Google Scholar
• Ekici, R., M. Sundstrom, B. Thay, and K. Lejon. 2009. Enhanced capture of extramembranous IgM and IgG on B cells in the NOD mouse – implications for immune complex trapping. Int. Immunol. 21: 533–541
   PubMed Web of Science ®Google Scholar
• Sundstrom, M., and K. Lejon. 2007. Idd-linked genetic regulation of TACIhigh expressing B cells in NOD mice. J. Autoimmun. 29: 116–124
   PubMed Web of Science ®Google Scholar
• Sundstrom, M., and K. Lejon. 2010. The prolonged and enhanced immune response in the non-obese diabetic mouse is dependent on genes in the Idd1/24, Idd12 and Idd18 regions. J. Autoimmun. 35: 375–382
   PubMed Web of Science ®Google Scholar
• Xiu, Y., C. P. Wong, J. D. Bouaziz, et al. 2008. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions. J. Immunol. 180: 2863–2875
   PubMed Web of Science ®Google Scholar
• Hjelm, F., F. Carlsson, A. Getahun, and B. Heyman. 2006. Antibody-mediated regulation of the immune response. Scand. J. Immunol. 64: 177–184
   PubMed Web of Science ®Google Scholar
• Rudolph, A. K., P. D. Burrows, and M. R. Wabl. 1981. Thirteen hybridomas secreting hapten-specific immunoglobulin E from mice with Iga or Igb heavy chain haplotype. Eur. J. Immunol. 11: 527–529
   PubMed Web of Science ®Google Scholar
• Ware, C. F., J. L. Reade, and L. C. Der. 1984. A rat anti-mouse kappa chain specific monoclonal antibody, 187.1.10: purification, immunochemical properties and its utility as a general second-antibody reagent. J. Immunol. Methods. 74: 93–104
   PubMed Web of Science ®Google Scholar
• Henningsson, F., Z. Ding, J. S. Dahlin, et al. 2011. IgE-mediated enhancement of CD4+ T cell responses in mice requires antigen presentation by CD11c+ cells and not by B cells. PLoS One. 6: e21760
   PubMed Web of Science ®Google Scholar
• Conrad, D. H. 1990. Fc epsilon RII/CD23: the low affinity receptor for IgE. Ann. Rev. Immunol. 8: 623–645
   PubMed Web of Science ®Google Scholar
• Rogosch, T., S. Kerzel, L. Sikula, et al. 2010. Plasma cells and nonplasma B cells express differing IgE repertoires in allergic sensitization. J. Immunol. 184: 4947–4954
   PubMed Web of Science ®Google Scholar
• Forsgren, S., A. Andersson, V. Hillorn, et al. 1991. Immunoglobulin-mediated prevention of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Scand. J. Immunol. 34: 445–451
   PubMed Web of Science ®Google Scholar
• Astorri, E., M. Bombardieri, S. Gabba, et al. 2010. Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets. J. Immunol. 185: 3359–3368
   PubMed Web of Science ®Google Scholar
• Natter, S., S. Seiberler, P. Hufnagl, et al. 1998. Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients. FASEB J. 12: 1559–1569
   PubMed Web of Science ®Google Scholar
• Permin, H., and A. Wiik. 1978. The prevalence of IgE antinuclear antibodies in rheumatoid arthritis and systemic lupus erythematosus. Acta Pathol. Microbiol. Scand. Sect. C Immunol. 86C: 245–249
   PubMedGoogle Scholar
• Phillippi, J., Y. Xie, D. R. Miller, et al. 2014. Using the emerging Collaborative Cross to probe the immune system. Genes Immun. 15: 38–46
   PubMed Web of Science ®Google Scholar
• Stolp, J., E. Marino, M. Batten, et al. 2013. Intrinsic molecular factors cause aberrant expansion of the splenic marginal zone B cell population in nonobese diabetic mice. J. Immunol. 191: 97–109
   PubMed Web of Science ®Google Scholar
• Rolf, J., V. Motta, N. Duarte, et al. 2005. The enlarged population of marginal zone/CD1d(high) B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11. J. Immunol. 174: 4821–4827
   PubMed Web of Science ®Google Scholar
• Kehry, M. R., and L. C. Yamashita. 1989. Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing. Proc. Natl. Acad. Sci. USA. 86: 7556–7560
   PubMed Web of Science ®Google Scholar
• Mudde, G. C., R. Bheekha, and C. A. Bruijnzeel-Koomen. 1995. IgE-mediated antigen presentation. Allergy. 50: 193–199
   PubMed Web of Science ®Google Scholar
• Mudde, G. C., T. T. Hansel, F. C. von Reijsen, et al. 1990. IgE: an immunoglobulin specialized in antigen capture? Immunol. Today. 11: 440–443
   PubMedGoogle Scholar
• Pirron, U., T. Schlunck, J. C. Prinz, and E. P. Rieber. 1990. IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE. Eur. J. Immunol. 20: 1547–1551
   PubMed Web of Science ®Google Scholar